Skip to main content

Table 1 Descriptive results and bivariable comparisons between PWUDs who were willing versus not willing to use a DCR

From: Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey)

Parameter

Total

n (%)

Will use DCR

n (%)

Will not use DCR

n (%)

p value

Location of the survey

 Harm reduction center

67 (34.7)

52 (41.9)

15 (21.7)

 < 0.0001

 Addiction unit

91 (47.2)

40 (32.3)

51 (73.9)

 

 Street

35 (18.1)

32 (25.8)

3 (4.4)

 

Gender

 Male

155 (80.3)

101 (81.5)

54 (78.3)

0.612

 Female

37 (19.2)

22 (17.7)

15 (21.7)

 

 Non binary

1 (0.5)

1 (0.8)

0 (0.0)

 

Mean age (±SD) (nmv = 3)

38.52 (± 9.35)

38.13 (± 9.67)

39.24 (± 8.81)

0.437

Current activity (nmv = 3)

 Yes

61 (32.1)

33 (27.3)

28 (40.6)

0.059

 No

129 (67.9)

88 (72.7)

41 (59.4)

 

Marital status (nmv = 1)

 Alone

117 (60.9)

82 (66.7)

35 (50.8)

0.058

 In couple

42 (21.9)

25 (20.3)

17 (24.6)

 

 Living with family/friends/other

33 (17.2)

16 (13.0)

17 (24.6)

 

Dependent children (nmv = 3)

 Yes

30 (15.8)

15 (12.4)

15 (21.7)

0.089

 No

160 (84.2)

106 (87.6)

54 (78.3)

 

Housing location

 Lyon

178 (92.2)

116 (93.6)

62 (89.9)

0.358

 Other (Departmental, regional, national)

15 (7.8)

8 (6.4)

7 (10.1)

 

Type of housing

 Stable

97 (50.3)

58 (46.8)

39 (56.5)

0.194

 Unstable (Street/squat/foster home/friends/family)

96 (49.7)

66 (53.2)

30 (43.5)

 

Social insurance for the precarious (nmv = 26)

 Yes

90 (53.9)

71 (66.4)

19 (31.7)

 < 0.0001

 No

77 (46.1)

36 (33.6)

41 (68.3)

 

HIV status (nmv = 1)

 Positive

7 (3.7)

6 (4.9)

1 (1.4)

0.394

 Negative

174 (90.6)

111 (90.2)

63 (91.3)

 

 Unknown

11 (5.7)

6 (4.9)

5 (7.3)

 

HCV serology status (nmv = 1)

 Positive (untreated and cured)

39 (20.3)

32 (26.0)

7 (10.1)

0.015

 Negative

132 (68.8)

76 (61.8)

56 (81.2)

 

 Unknown

21 (10.9)

15 (12.2)

6 (8.7)

 

HBV status (nmv = 2)

 Positive

7 (3.7)

4 (3.3)

3 (4.4)

0.062

 Negative

141 (73.8)

84 (68.8)

57 (82.6)

 

 Unknown

43 (22.5)

34 (27.9)

9 (13.0)

 

Drug used

 Alcohol

140 (72.5)

93 (75.0)

47 (68.1)

0.304

 Tobacco

178 (92.2)

114 (91.9)

64 (92.7)

0.839

 Cannabis

144 (74.6)

101 (81.4)

43 (62.3)

0.003

 Cocaine (crack included)

159 (82.4)

105 (84.7)

54 (78.3)

0.262

 Crack-cocaine form

98 (50.8)

72 (73.5)

26 (26.5)

0.007

 Amphetamine

62 (32.1)

47 (37.9)

15 (21.7)

0.021

 Heroin

97 (50.3)

60 (48.4)

37 (53.6)

0.486

 Morphine

57 (29.5)

45 (36.3)

12 (17.4)

0.006

 Benzodiazepine

95 (49.2)

68 (54.8)

27 (39.1)

0.036

 Pregabalin

9 (4.7)

6 (4.8)

3 (4.3)

0.877

 Methylphenidate

2 (1.0)

1 (0.8)

1 (1.4)

0.673

 Cathinones

12 (6.2)

6 (4.8)

6 (8.7)

0.288

 Methadone (without prescription)

35 (18.1)

26 (21.0)

9 (13.0)

0.171

 Buprenorphine (without prescription)

35 (18.1)

29 (23.4)

6 (8.7)

0.011

 Other: ketamine, mushrooms, LSD…

22 (11.4)

15 (12.1)

7 (10.1)

0.683

Materials utilized

 Syringes

59 (30.6)

46 (37.1)

13 (18.8)

0.008

 Snorting straws

100 (51.8)

54 (43.5)

46 (66.7)

0.002

 Crack pipes

49 (25.4)

36 (29.0)

13 (18.8)

0.119

 Other

22 (11.4)

12 (9.7)

10 (14.5)

0.313

Consumption habits

 Always with partners

160 (83.3)

106 (86.2)

54 (78.3)

0.158

 Always in a precarious place

33 (17.1)

21 (16.9)

12 (17.4)

0.936

 Occasional in a precarious place

168 (87.0)

111 (89.5)

57 (82.6)

0.171

 In public space (i.e., street, toilets, and stairwell)

138 (71.5)

99 (71.7)

39 (28.3)

0.001

Problems experienced with

 Residents, shopkeepers, customers… (nmv = 34)

63 (39.6)

54 (52.9)

9 (15.8)

 < 0.0001

 Police (mmv = 34)

43 (27.0)

36 (35.3)

7 (12.3)

0.002

PWUDs perceived as being a nuisance (nmv = 67)

 Yes

60 (47.6)

42 (57.5)

18 (34.0)

0.009

 No

66 (52.4)

31 (42.5)

35 (66.0)

 

Drug preparation and drug use habits

 Mean time (min) to prepare (±SD) (nmv = 4)

6.00 (± 4.62)

6.34 (± 4.48)

5.41 (± 4.82)

0.180

 Mean time (min) to consume (±SD) (nmv = 13)

21.32 (± 65.23)

17.54 (± 51.08)

28.00 (± 84.75)

0.303

 Number of consumptions per day (±SD) (nmv = 18)

5.11 (± 4.58)

4.81 (± 4.17)

5.62 (± 5.18)

0.256

 Start time (hour) of consumption (±SD) (nmv = 30)

11.50 (± 4.47)

11.47 (± 4.27)

11.56 (± 4.84)

0.903

 Finish time (hour) of consumption (±SD) (nmv = 35)

13.57 (± 9.45)

14.09 (± 9.52)

12.64 (± 9.34)

0.360

Police intervention during drug use (nmv = 7)

 Yes

59 (31.7)

49 (40.8)

10 (15.1)

 < 0.001

 No

127 (68.3)

71 (59.2)

56 (84.9)

 

Access to a water point (nmv = 9)

 Yes

70 (38.0)

35 (30.2)

35 (51.5)

0.004

 Sometimes

72 (39.2)

47 (40.5)

25 (36.7)

 

 No

42 (22.8)

34 (29.3)

8 (11.8)

 

Loan of materials (nmv = 2)

 Yes

47 (24.6)

36 (29.5)

11 (15.9)

0.037

 No

144 (75.4)

86 (70.5)

58 (84.1)

 

Reuses materials (nmv = 1)

 Yes

148 (77.1)

102 (82.9)

46 (66.7)

0.010

 No

44 (22.9)

21 (17.1)

23 (33.3)

 

Fate of the material

 Clean disposal (container, pharmacy…)

71 (36.8)

57 (46.0)

14 (20.3)

 < 0.001

 Inappropriate disposal (street, garbage can…)

122 (63.2)

67 (54.0)

55 (79.7)

 

About opioid overdose

 History of overdose

56 (29.0)

39 (31.4)

17 (24.6)

0.317

 Number of overdose (±SD) (nmv = 2)

54 (96.4)

2.08 (± 1.77)

1.76 (± 1.09)

0.501

 Knows about THN

126 (65.6)

86 (69.9)

40 (58.0)

0.094

 Ever used intranasal THN (nmv = 3)

16 (8.4)

9 (7.3)

7 (10.4)

0.458

 Ever used intramuscular THN (nmv = 7)

4 (2.2)

4 (3.3)

0 (0.0)

0.138

THN preferences (nmv = 9)

 Intranasal

53 (28.8)

30 (25.6)

23 (34.3)

0.434

 Intramuscular

19 (10.3)

12 (10.3)

7 (10.5)

 

 No matter

112 (60.9)

75 (64.1)

37 (55.2)

 

Treated by OAT

 Yes

127 (65.8)

82 (66.1)

45 (65.2)

0.898

 No

66 (34.2)

42 (33.9)

24 (34.8)

 

Type of OAT prescribed (nmv = 2)

 Buprenorphine

60 (48.0)

44 (55.0)

16 (35.6)

0.055

 Methadone

60 (48.0)

32 (40.0)

28 (62.2)

 

 Morphine

5 (4.0)

4 (5.0)

1 (2.2)

 

Routes of OAT administration (nmv = 1)

 Only those authorized

71 (56.4)

39 (47.6)

32 (72.7)

0.007

 Diverted (snorted, injected, both)

55 (43.6)

43 (52.4)

12 (27.3)

 

Diverted routes of OAT administration (nmv = 1)

 Injected

35 (63.6)

29 (67.4)

6 (50.0)

0.534

 Snorted

17 (30.9)

12 (27.9)

5 (41.7)

 

 Both

3 (5.5)

2 (4.7)

1 (8.3)

 

Main obstacle for OAT use (nmv = 9)

 Inappropriate treatment

52 (28.2)

39 (32.3)

13 (20.6)

0.023

 Difficult access to an addiction center

32 (17.4)

27 (22.3)

5 (7.9)

 

 Difficult access to doctor

29 (15.8)

13 (10.7)

16 (25.4)

 

 Difficulty in following up

20 (10.9)

13 (10.7)

7 (11.1)

 

 Difficulties related to other consumption

8 (4.3)

4 (3.3)

4 (6.4)

 

 Nothing

18 (9.8)

11 (9.1)

7 (11.1)

 

 Other/not concerned

25 (13.6)

14 (11.6)

11 (17.5)

 

Places of consultation (nmv = 4)

 None

37 (19.6)

27 (22.3)

10 (14.7)

0.045

 Addiction center

114 (60.3)

65 (53.7)

49 (72.1)

 

 Office based

38 (20.1)

29 (24.0)

9 (13.2)

 

Users' wishes

 New addiction center (nmv = 13)

135 (75.0)

83 (73.4)

52 (77.6)

0.533

 New harm reduction center (nmv = 13)

147 (81.7)

98 (87.5)

49 (72.1)

0.009

 A low threshold methadone bus (nmv = 17)

135 (76.7)

89 (80.2)

46 (70.8)

0.154

 Drug consumption rooms (nmv = 3)

165 (86.8)

119 (97.5)

46 (67.6)

 < 0.0001

 New automatic syringe dispenser (nmv = 17)

144 (81.8)

95 (88.0)

49 (72.1)

0.008

 New hospital-based withdrawal service (nmv = 22)

150 (87.7)

88 (84.6)

62 (92.5)

0.123

 More psychiatric consultations (nmv = 17)

131 (74.4)

78 (72.2)

53 (77.9)

0.397

 More hosting solutions (nmv = 12)

156 (86.2)

106 (93.8)

50 (73.5)

 < 0.001

  1. p-values <0.05 are shown in bold
  2. DCR drug consumption room, HCV hepatitis C virus, HBV hepatitis B virus, HIV human immunodeficiency viruses, MA marketing authorization, nmv number of missing values, PWUDs people who use drugs, OAT Opioid agonist treatment, THN take home naloxone, SD standard deviation